Dr. Robert F. Cornell, MD

Dr. Cornell practices at Columbia University Irving Medical Center in New York, New York.

Dr. Cornell's NPI, 1619199486, was assigned on May 2, 2007. Dr. Cornell holds Tennessee license MD50142.

Dr. Cornell's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 305-4920.

Dr. Cornell's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Cornell is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Cornell to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cornell practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Cornell's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Cornell's licenses on file in 3 states: Tennessee, Illinois and Wisconsin.

CMS data shows 57 Medicare services from Dr. Cornell across 1 procedure code in 2024, for 41 Medicare patients. Medicare paid $3,690 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Dr. Cornell in 2024. The largest group is 75 to 84, with 20 patients. 75% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 3.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cornell's median patient age at 71, with 47% women.

In 2020, Dr. Cornell wrote 120 Medicare Part D claims. They cover 5 drugs, with $771,664 in total drug cost. In 2019, CMS named 488 claims across 10 drugs.

Dr. Cornell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 62 general payments to Dr. Cornell from 14 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 82% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $12,231. It also lists 24 research payments totaling $518,699 from 2018 to 2020.